Concepedia

Author

Maikel V. W. van der Velden

Baxter (Austria)

Also Known As

M. V. W. van der Velden, Maikel V. W. van der Velden, Maikel V.W. van der Velden, Maikel V. W. van der Velden

7

Publications

181

Citations

6

H-Index

8

Concepts

All Affiliations

Baxter (Austria)Baxter (United States)Vienna General HospitalMedical University of ViennaTampere University
MV

About

Maikel V. W. van der Velden is an author at Baxter (Austria) specializing in vaccination, influenza vaccines, and cell culture.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

26

2

Immunology

1

1

26

3

Vaccine Development

1

1

26

4

Cell Culture

1

1

26

5

Cross-protection

1

1

26

Maikel V. W. van der Velden

×

6

Publications

178

Citations

6

H-Index

YearCitations

A Cell Culture (Vero)–Derived H5N1 Whole‐Virus Vaccine Induces Cross‐Reactive Memory Responses

Hartmut J. Ehrlich, Markus Müller, Sandor Fritsch,

The Journal of Infectious Diseases

2009

50

An Inactivated Ross River Virus Vaccine Is Well Tolerated and Immunogenic in an Adult Population in a Randomized Phase 3 Trial

Nina Wressnigg, Maikel V. W. van der Velden, Daniel Portsmouth,

Clinical and Vaccine Immunology

2014

46

Safety and Immunogenicity of a Vero Cell Culture-Derived Whole-Virus Influenza A(H5N1) Vaccine in a Pediatric Population

Maikel V. W. van der Velden, Richard Fritz, Daniel Portsmouth,

The Journal of Infectious Diseases

2013

32

Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: Homologous or heterologous booster response following two dose or single dose priming

Maikel V. W. van der Velden, Gerald Aichinger, Alexandra Löw‐Baselli,

Vaccine

2012

26

Safety and Immunogenicity of a Vero Cell Culture-Derived Whole-Virus H5N1 Influenza Vaccine in Chronically Ill and Immunocompromised Patients

Maikel V. W. van der Velden, Alexander Geisberger, Thomas Dvorak,

Clinical and Vaccine Immunology

2014

13

Phase I/II Randomized Double-Blind Study of the Safety and Immunogenicity of a Nonadjuvanted Vero Cell Culture-Derived Whole-Virus H9N2 Influenza Vaccine in Healthy Adults

Gerald Aichinger, Barbara Grohmann-Izay, Maikel V. W. van der Velden,

Clinical and Vaccine Immunology

2014

11

Page 1